Oxford Biomedica, (OXB). Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Biomedica, (OXB).

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Oily1	2/7/2005 3:14:10 AM
	of 111

Termination of discussions On 19 January 2005 the Board of Oxford BioMedica announced that it had received an approach from a third party regarding a potential merger, which may or may not lead to an offer for the Company. The Board of Oxford BioMedica announces that the discussions that followed this unsolicited approach have terminated. 7 February 2005 Enquiries: Oxford BioMedica plc Tel: +44 (0) 1865 783000 Professor Alan Kingsman, Chief Executive Officer Rothschild Tel: +44 (0) 20 7280 5000 Dr. Lynn Drummond N M Rothschild & Sons Limited ("Rothschild"), which is authorised and regulated by the Financial Services Authority in the United Kingdom, acts for Oxford BioMedica plc and no one else in relation to the contents of this announcement and will not be responsible to anyone other than Oxford BioMedica plc for providing the protections afforded to clients of Rothschild nor for providing advice in relation to the contents of this announcement. This information is provided by RNS The company news service from the London Stock Exchange END OTTPKAKBDBKBKBK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next